Close Menu

    Get the latest news around the globe

    Editor's Pick

    Evergrande shares surge as trading resumes amid crisis

    Struggling with bloating? Try these tips to get good results

    Emissions divide is greater within countries than between them; Study

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) LinkedIn Instagram
    Britain HeraldBritain Herald
    Subscribe
    • Home
    • World Roundup
    • Business
    • Tech World
    • Entertainment & Events
    • Curious
    • More…
      • Spotlight
      • Knowledge
      • Lifestyle
      • Awareness
      • Women World
      • Sports
      • Travel
      • Notable
      • Contact Us
    Britain HeraldBritain Herald
    Home » Multiple Sclerosis drug could treat Alzheimer’s; Scientists
    Home News

    Multiple Sclerosis drug could treat Alzheimer’s; Scientists

    Currently, over 55 million people globally have dementia, and by the middle of this century, it's projected to increase to nearly 140 million.
    News DeskBy News DeskSeptember 5, 2023
    Facebook Twitter LinkedIn WhatsApp
    Belly Fat Study
    Rep. Image | rawpixel.com @ Freepik

    London, UK: In a new study, scientists suggest that an oral medication approved for treating Multiple Sclerosis (MS) could potentially help to slow down the harmful inflammation associated with Alzheimer’s disease.

    The pharmaceutical drug Ponesimod received approval from both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to treat multiple sclerosis in 2021 after successfully completing clinical trials.

    Experiments carried out by University of Kentucky researchers have provided evidence that the drug can inhibit excessive immune activity in the nervous system, a process believed to be crucial in the development of dementia.

    lung cancer pill reduces risk of death by half
    Rep. Image: JESHOOTS.com @ Pexels

    “We are the first to show that Ponesimod is effective in a mouse model for Alzheimer’s disease,” neuroscientist Mr. Erhard Bieberich, the principal investigator of the study, said.

    The researchers used genetically modified mice with Alzheimer’s-like characteristics and brain tissue samples from deceased Alzheimer’s patients. They studied how sphingolipids influence microglia activity and the outcomes of blocking them.

    The results appear promising, as there are evident indications that Ponesimod reduces pro-inflammatory cytokines and initiates anti-inflammatory signals that promote microglia to ingest problematic protein clusters and tangles in the brain, as per the researchers.

    Study on Alzheimer's Drug Donanemab
    Rep. Image | Andrea Piacquadio @ Pexels

    In our study, we reprogrammed microglia into neuron-protective cells that clean up toxic proteins in the brain, reduce Alzheimer’s neuroinflammatory pathology, and improve memory in the mouse model.

    The study’s lead author, Mr. Zhihui Zhu, remarked.

    Currently, over 55 million people globally have dementia. By the middle of this century, it’s projected to increase to nearly 140 million as the ageing population grows, with the majority of this increase occurring in developing countries.

    RECOMMENDED | Online puzzle games might benefit memory in elderly adults; Study

    STAR OF SECTOR 2025
    Alzheimer's Alzheimer's Disease Alzheimer's Study European Medicines Agency Multiple Sclerosis Multiple Sclerosis Drug Multiple Sclerosis Medication US Food and Drug Administration
    Share. Facebook Twitter LinkedIn WhatsApp
    Avatar
    News Desk

    The news/article published above has been sourced, compiled, and corroborated by a member of the Britain Herald News Desk Team. If you have any queries or complaints about the published material, please get in touch with us at BritainHerald@Gmail.Com

    Newly Updated

    Robert Prevost becomes Pope Leo XIV, first American Pontiff

    May 9, 2025

    Brazil urges climate governance reform ahead of COP30

    May 8, 2025

    Victory Day Parade: Putin welcomes world leaders to Moscow

    May 8, 2025
    STAR OF SECTOR 2025

    Business

    MJ Mathew Takes Executive Role at WellMade Network

    Business May 8, 2025

    WellMade Network, headquartered in Sharjah Publishing City, UAE, has further strengthened its executive leadership with…

    UK and India sign trade deal to slash tariffs and boost exports

    May 7, 2025

    DoorDash to take over Deliveroo in landmark international deal

    May 6, 2025

    Elon Musk’s ‘Starbase’ inches closer to reality in Texas vote

    May 3, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • LinkedIn
    • Instagram

    Curious

    Glowing Spiral appears in night sky; Linked to SpaceX Falcon 9 Rocket

    March 25, 2025

    Once dubbed ‘Ugliest’; Blobfish triumphs as NZ ‘Fish of the Year’

    March 19, 2025

    Giant Iceberg A23a runs aground near South Georgia; Easing wildlife fears

    March 5, 2025

    NASA Astronauts to return after nine months in Space

    March 5, 2025

    Get the latest news around the globe

    Knowledge

    Snakebite survivor’s blood sparks universal antivenom discovery

    Science May 3, 2025

    San Francisco, USA: Scientists say a major step toward developing a universal antivenom has emerged…

    ESA’s Biomass satellite set for launch to map forest carbon

    April 29, 2025

    Gigil: The new dictionary word for irresistible cuteness overload

    March 27, 2025

    Finland tops 2025 World Happiness Report; US falls to new low

    March 20, 2025
    18-EA-387-TryEngineeringSummerInst_BannerAd_300x250_Robot
    About Us
    About Us

    Britain Herald is a global news brand that plays a significant role in educating and informing the masses with informative content, the latest updates, and current affairs across the World.

    Operated and Managed by WellMade Network, the portal is a sister concern of GCC Business News and Emirati Times. For inquiries about Media Partnerships, Investment and other opportunities in line with our Editorial Policy, please contact us at;

    Email Us: News@BritainHerald.com
    Whatsapp: +971 5060 12456

    We Have

    Robert Prevost becomes Pope Leo XIV, first American Pontiff

    May 9, 2025

    MJ Mathew Takes Executive Role at WellMade Network

    May 8, 2025

    Brazil urges climate governance reform ahead of COP30

    May 8, 2025

    Victory Day Parade: Putin welcomes world leaders to Moscow

    May 8, 2025
    Facebook X (Twitter) LinkedIn Instagram
    • Home
    • Business
    • Tech World
    • Awareness
    • Contact Us
    Privacy & Cookies Policy | Terms & Conditions
    © 2002 BritainHerald.com, An Initiative by WellMade Network

    Type above and press Enter to search. Press Esc to cancel.